Veracyte (FRA:12V) Shares Buyback Ratio % : -2.46 (As of May. 09, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Veracyte Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Veracyte's current shares buyback ratio was -2.46%.

Veracyte Shares Buyback Ratio % Historical Data

The historical data trend for Veracyte's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Shares Buyback Ratio % Chart

Veracyte Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-17.28

-22.20

-1.18

-1.81

-6.15

Veracyte Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Shares Buyback Ratio %	Get a 7-Day Free Trial															-4.31	-0.42	-0.97	-0.36	-0.69

Veracyte Shares Buyback Ratio % Calculation

Veracyte's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(73.265	-	77.773)	/	73.265
	=	-6.15%

Veracyte's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2024 )	-	Shares Outstanding (EOP) (A: Mar. 2025 ))	/	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	(77.773	-	78.306)	/	77.773
	=	-0.69%

Veracyte Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Veracyte's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Veracyte Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

VCYT:USA

Address

6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.veracyte.com

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Veracyte Headlines

No Headlines